apomorphine has been researched along with squamosamide in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bao, X; Tai, W; Wang, X; Ye, X; Zhang, D; Zhao, B | 1 |
| Bao, XQ; Kong, LB; Kong, XC; Sun, H; Wu, LY; Zhang, D | 1 |
2 other study(ies) available for apomorphine and squamosamide
| Article | Year |
|---|---|
Inhibition of Src tyrosine kinase activity by squamosamide derivative FLZ attenuates neuroinflammation in both in vivo and in vitro Parkinson's disease models.
Topics: Animals; Apomorphine; Benzeneacetamides; Cell Line; Disease Models, Animal; Dopamine Agonists; Dose-Response Relationship, Drug; Encephalitis; Enzyme Activation; Enzyme Activators; Exploratory Behavior; Lipopolysaccharides; Male; Mice; Motor Activity; Parkinson Disease; Phenols; Rats; Rats, Wistar; src-Family Kinases | 2013 |
Squamosamide derivative FLZ protected dopaminergic neuron by activating Akt signaling pathway in 6-OHDA-induced in vivo and in vitro Parkinson's disease models.
Topics: alpha-Synuclein; Animals; Apomorphine; Benzeneacetamides; Cell Death; Disease Models, Animal; Dopamine Agonists; Dopaminergic Neurons; Male; Motor Activity; Neuroprotective Agents; Oxidopamine; Parkinson Disease; Phenols; Proto-Oncogene Proteins c-akt; Rats; Rats, Wistar; Repressor Proteins; Signal Transduction; Transcription Factors; Tyrosine 3-Monooxygenase | 2014 |